PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells. (2nd January 2016)

• Record Type: Journal Article
• Authors: Zhou, Xiang; Zhao, Xinli; Li, Xiangsheng; Ping, Guanfang; Pei, Sujuan; Chen, Ming; Wang, Zhongwei; Zhou, Wenke; Jin, Baozhe
• Is Part Of: Journal of chemotherapy. Volume 28:Number 1(2016:Feb.)
• Page Start: 44
• Page End: 49
• Publication Date: 2016-01-02
• Subjects: Glioma -- IGF1-R -- PQ401 -- U87MG -- Proliferation -- Migration; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; 615.58
• DOI: 10.1179/1973947815Y.0000000026
• Languages: English
• ISSNs: 1120-009X

Abstract

Abstract : Growth factor signalling pathways transduce extra-cellular physiological cues to guide cells to maintain critical cellular functions, including cell proliferation, survival and metabolism. Dysregulation of certain growth factor signalling pathways has been shown as a major route to promote tumourigenesis. Glioma is a type of aggressive malignant tumour with no effective systematic therapy so far. Overexpression or hyperactivation of IGF-1R has been observed to be tightly associated with glioma progression and poor prognosis. Here, we examined the biological effects of a specific IGF-1R inhibitor, PQ401, on suppressing U87MG glioma cell growth and migration. Specifically, we observed that PQ401 not only induced cellular apoptosis in U87MG cells and subsequently reduced cell viability and proliferation but also attenuated cell mobility in vitro . More importantly, through a mouse xenograft model, we observed that administration of PQ401 on mice led to suppression of glioma tumour growth in vivo . In summary, our study suggests that PQ401 may serve as a promising leading drug for treating glioma patients with elevated IGF-1R signalling.